A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
Abroad (travel likely)Recruiting
Conditions
Prostatic Neoplasms · Metastatic Hormone-sensitive Prostate Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre Francois Baclesse, Caen, France
Study leads
Janssen-Cilag France Clinical Trial
Study Director
Janssen-Cilag France